News

Meta-Analysis Links Acid Suppression to C. difficile Risk


 

FROM THE EUROPEAN CONGRESS OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES

The exact reason for the association between acid suppression and CDI has not been clearly elucidated. Gastric acid does not kill C. difficile spores, but it does kill the vegetative form of C. difficile, the survival of which with acid-suppression therapy could play a role in pathogenesis. Acid-suppression therapy has also been shown to delay gastric emptying, which could improve survival of the vegetative form, he explained.

Dr. Tleyjeh stated that he had no relevant financial disclosures.

Pages

Recommended Reading

Acetaminophen Safe in Alcoholics, Analysis Suggests
MDedge Internal Medicine
Underlying Health Conditions May Boost C. difficile Risk in Kids
MDedge Internal Medicine
Abatacept May Aid RA Patients With Hepatitis B
MDedge Internal Medicine
Duodenal GIST Responds to Surgery, Imatinib
MDedge Internal Medicine
Fecal Transplant Tackles C. diff; Linezolid Good for MRSA Pneumonia
MDedge Internal Medicine
Wide Disparity in Appendicitis Costs Observed
MDedge Internal Medicine
Variceal Rebleeding Twice as Likely If Beta-Blockers Fail
MDedge Internal Medicine
Infliximab Called 'Optimal' for Refractory Ulcerative Colitis
MDedge Internal Medicine
Intensive Follow-Up Reduces Mortality From Hepatocellular Cancer
MDedge Internal Medicine
Data Supporting Probiotics' Benefit Found Weak but Favorable
MDedge Internal Medicine